ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,485Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 2588

$1.43M Total Retail Price of All Prescriptions

Rank: 28 out of 2588

874 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 874 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

20% of this provider’s 874 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 25,656 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
AMLODIPINE BESYLATE 1,249 1,175 1 4
LISINOPRIL 1,200 1,041 2 3
LEVOTHYROXINE SODIUM 1,189 1,041 3 2
OMEPRAZOLE 1,056 946 4 6
HYDROCODONE-ACETAMINOPHEN 1,000 799 S3 5 7
FUROSEMIDE 929 858 6 5
PRAVASTATIN SODIUM 838 687 7 16
WARFARIN SODIUM 822 735 8 10
METOPROLOL TARTRATE 593 527 9 9
METOPROLOL SUCCINATE 580 539 10 12
HYDROCHLOROTHIAZIDE 574 506 11 13
SIMVASTATIN 537 489 12 1
POTASSIUM CHLORIDE 485 445 13 15
CITALOPRAM HBR 425 331 14 27
DONEPEZIL HCL 362 361 15 22
ATENOLOL 357 280 16 14
TRAMADOL HCL 345 301 17 19
GLIMEPIRIDE 343 315 18 39
ATORVASTATIN CALCIUM 318 304 19 11
METFORMIN HCL 316 273 20 8
PANTOPRAZOLE SODIUM 305 286 21 28
CARVEDILOL 291 270 22 20
GABAPENTIN 267 220 23 18
DIOVAN 266 252 24 29
ZOLPIDEM TARTRATE 265 190 25 24
DOXAZOSIN MESYLATE 254 252 26 96
NAMENDA 249 249 27 32
RANITIDINE HCL 239 146 28 37
CYMBALTA 216 180 29 70
POLYETHYLENE GLYCOL 3350 212 204 30 55
METFORMIN HCL ER 202 163 31 67
ALLOPURINOL 202 175 31 33
LOSARTAN POTASSIUM 198 198 33 17
ROPINIROLE HCL 197 189 34 113
CLOPIDOGREL 184 155 35 30
CLONIDINE HCL 184 160 35 54
CEPHALEXIN 181 159 37 138
ESCITALOPRAM OXALATE 177 177 38 68
KLOR-CON M20 170 156 39 52
SPIRIVA 168 124 40 56
ISOSORBIDE MONONITRATE ER 168 167 40 49
LISINOPRIL-HYDROCHLOROTHIAZIDE 167 148 42 35
DIGOXIN 163 163 43 38
GLIPIZIDE 162 128 44 44
PREDNISONE 150 117 45 42
CRESTOR 143 130 46 25
GEMFIBROZIL 143 105 46 123
FLUTICASONE PROPIONATE 141 103 48 40
TRAZODONE HCL 140 118 49 61
SPIRONOLACTONE 133 125 50 58
PROAIR HFA 132 79 51 50
AZITHROMYCIN 130 108 52 45
INSULIN SYRINGE 129 113 53 81
AMLODIPINE BESYLATE-BENAZEPRIL 123 112 54 76
PEN NEEDLE 122 88 55 112
LOSARTAN-HYDROCHLOROTHIAZIDE 122 122 55 66
ALENDRONATE SODIUM 119 118 57 21
SINGULAIR 119 97 57 94
MONTELUKAST SODIUM 117 90 59 153
LANTUS SOLOSTAR 116 74 60 93
TAMSULOSIN HCL 115 104 61 23
PLAVIX 114 94 62 43
MELOXICAM 111 83 63 51
CARBIDOPA-LEVODOPA 107 97 64 83
NEXIUM 106 93 65 41
BENAZEPRIL HCL 105 93 66 84
SERTRALINE HCL 104 104 67 26
ADVAIR DISKUS 103 78 68 48
NOVOLOG 101 101 69 103
FAMOTIDINE 101 73 69 36
ZETIA 100 94 71 69
ENALAPRIL MALEATE 99 83 72 31
KLOR-CON 10 95 95 73 75
LANTUS 95 79 73 47
FENTANYL 93 83 S2 75 78
DIOVAN HCT 87 80 76 72
TRICOR 84 74 77 122
CIPROFLOXACIN HCL 83 77 78 82
COMBIVENT 82 49 79 145
SYNTHROID 81 80 80 88
DILTIAZEM ER 79 68 81 150
ACTOS 79 79 81 105
CELEBREX 79 61 81 99
FENOFIBRATE 78 32 84 64
NASONEX 77 72 85 218
BYSTOLIC 77 68 85 110
AMOXICILLIN 75 67 87 130
LACTULOSE 74 69 88 135
PREMARIN 71 48 R 89 247
JANUVIA 71 71 89 60
TRILIPIX 70 56 91 185
LEVOFLOXACIN 70 63 91 77
PHENYTOIN SODIUM EXTENDED 69 26 93 109
DILTIAZEM 24HR CD 69 66 93 98
DILTIAZEM 24HR ER 67 67 95 166
RISPERIDONE 66 62 96 57
NOVOLOG MIX 70-30 65 46 97 271
IPRATROPIUM-ALBUTEROL 64 62 98 104
LYRICA 63 39 99 100
PRAMIPEXOLE DIHYDROCHLORIDE 63 47 99 188
MIRTAZAPINE 63 60 99 63
SYMBICORT 62 44 102 129
VYTORIN 62 62 102 200
CYCLOBENZAPRINE HCL 62 16 R 102 87
DICLOFENAC SODIUM 57 31 105 124
FLUOXETINE HCL 57 46 105 92
FINASTERIDE 57 52 105 97
BUDESONIDE 56 53 108 383
ZOSTAVAX 56 52 108 312
AMITRIPTYLINE HCL 55 41 R 110 91
QUINAPRIL HCL 55 55 110 148
LEVEMIR FLEXPEN 54 53 112 220
VENLAFAXINE HCL ER 54 48 112 125
TRIAMTERENE-HCTZ 53 53 114 46
COUMADIN 52 52 115 165
BUSPIRONE HCL 52 40 115 173
LIPITOR 52 51 115 114
AVODART 52 52 115 164
LOVASTATIN 51 51 119 34
LEVOXYL 50 50 120 245
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 11, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.